Experienced in Hyperventilation

Dr. Hassan Alnuaimat

Intensive Care Medicine
Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, 
Gainesville, FL 
Experienced in Hyperventilation
Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hassan Alnuaimat is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Alnuaimat is rated as an Experienced provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Pulmonary Hypertension, Interstitial Lung Disease, Pulmonary Veno-Occlusive Disease, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 42 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hyperventilation.

Specialties
Intensive Care Medicine
Licenses
Anesthesiology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Uf Health Medical Specialties-Medical Plaza
1549 Gale Lemerand Dr, Gainesville, FL 32610
Call: 352-265-8940

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Combination product, Other
Study Drug: Extracorporeal Photopheresis (ECP)
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 10 Less Clinical Trials

42 Total Publications

Serpiginous-Like Choroiditis with ANCA-PR3 Vasculitis in a Patient from Endemic Country: A Complex Phenotypic, Immunological and Epidemiological Puzzle.
Serpiginous-Like Choroiditis with ANCA-PR3 Vasculitis in a Patient from Endemic Country: A Complex Phenotypic, Immunological and Epidemiological Puzzle.
Journal: Ocular immunology and inflammation
Published: December 10, 2024
View All 42 Publications
Similar Doctors
Experienced in Hyperventilation
Dr. Ali Ataya
Intensive Care Medicine
Experienced in Hyperventilation
Dr. Ali Ataya
Intensive Care Medicine

UF Health Pulmonary - Medical Specialties - Medical Plaza

1549 Gale Lemerand Dr, 
Gainesville, FL 
 (0.4 miles away)
352-273-8740
Languages Spoken:
English
See accepted insurances

Ali Ataya is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Ataya is rated as a Distinguished provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Pulmonary Alveolar Proteinosis, Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Transplant, and Fasciotomy.

Hiren Mehta
Experienced in Hyperventilation
Dr. Hiren Mehta
Intensive Care Medicine
Experienced in Hyperventilation
Dr. Hiren Mehta
Intensive Care Medicine

Uf Health Medical Lab-Shands Hospital

1600 SW Archer Rd, 
Gainesville, FL 
 (0.1 miles away)
352-273-8737
Languages Spoken:
English
See accepted insurances

Hiren Mehta is an Intensive Care Medicine provider in Gainesville, Florida. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Lung Nodules, Lung Cancer, Small Cell Lung Cancer (SCLC), Endoscopy, and Gastrostomy.

VIEW MORE HYPERVENTILATION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alnuaimat's expertise for a condition
ConditionClose
    • Distinguished
    • Interstitial Lung Disease
      Dr. Alnuaimat is
      Distinguished
      . Learn about Interstitial Lung Disease.
      See more Interstitial Lung Disease experts
    • Pulmonary Hypertension
      Dr. Alnuaimat is
      Distinguished
      . Learn about Pulmonary Hypertension.
      See more Pulmonary Hypertension experts
    • Advanced
    • Lung Transplant
      Dr. Alnuaimat is
      Advanced
      . Learn about Lung Transplant.
      See more Lung Transplant experts
    • Pneumonia
      Dr. Alnuaimat is
      Advanced
      . Learn about Pneumonia.
      See more Pneumonia experts
    • Pulmonary Veno-Occlusive Disease
      Dr. Alnuaimat is
      Advanced
      . Learn about Pulmonary Veno-Occlusive Disease.
      See more Pulmonary Veno-Occlusive Disease experts
    • Experienced
    • Acute Interstitial Pneumonia
      Dr. Alnuaimat is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Arteriovenous Malformation
      Dr. Alnuaimat is
      Experienced
      . Learn about Arteriovenous Malformation.
      See more Arteriovenous Malformation experts
    • Chronic Obstructive Pulmonary Disease (COPD)
      Dr. Alnuaimat is
      Experienced
      . Learn about Chronic Obstructive Pulmonary Disease (COPD).
      See more Chronic Obstructive Pulmonary Disease (COPD) experts
    • Empyema
      Dr. Alnuaimat is
      Experienced
      . Learn about Empyema.
      See more Empyema experts
    • Endoscopy
      Dr. Alnuaimat is
      Experienced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
      Dr. Alnuaimat is
      Experienced
      . Learn about Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome).
      See more Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome) experts
    View All 10 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.